Search Results - "Bernard‐Henry, C."

Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV‐1‐infected patients: a cohort study by Gantner, P, Reinhart, S, Partisani, M, Baldeyrou, M, Batard, M‐L, Bernard‐Henry, C, Cheneau, C, Mautort, E, Priester, M, Fafi‐Kremer, S, Muret, P, Rey, D

“…Objectives Emtricitabine/tenofovir/rilpivirine as a single‐tablet regimen (STR) is widely used without licence in treatment‐experienced patients. The purpose…”
Get full text

Prednisolone does not prevent the occurrence of nevirapine-induced rashes by REY, D, PARTISANI, M, KRANTZ, V, KEMPF, G, NICOLLE, M, DE MAUTORT, E, PRIESTER, M, BERNARD-HENRY, C, LANG, J.-M

“…Nevirapine (NVP) is a non-nucleoside reverse transcriptase HIV-1 inhibitor. Its most frequent side-effect is the development of a rash (usually within the…”
Get full text

Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH) by Marcellin, Fabienne, Abgrall, Sophie, Roustant, F, Platterier, P, Kmiec, I, Parlier, S, Anriamiandrisoa, S, Pomes, C, Mole, M, Mebarki, M, Ousidhoum, Y, Braik, O, Bayoud, R, Gatey, C, Ben Rayana, R, Lions, C, Zelie, J, Ogoudjobi, S, Thoirain‐Galvan, V, Gilbert, C, Ramier, C, Izopet, J, Valantin, Chas, J, Duvivier, C, Morlat, P, Autran, B, Solas, C, Fontaine, H, Piroth, L, Peytavin, G, Tremeaux, P, Cacoub, P, Charlotte, F, Marchou, B, Selves, J, Larroquette, F, Rio, V, De Monte, A, Giordanengo, V, Partouche, C, Baazia, Y, Garipuy, D, Nicot, F, Adle‐Biassette, H, Alexandre, G, Molina, J.M, Bertheau, P, Quertainmont, Y, Teicher, E, Rouzaud, C, Castet‐Lafarie, S, Cazanave, C, Dupon, M, Dutronc, H, Dauchy, F, Desclaux, A, Bonnet, F, Bernard, N, Martell, C, Vandenhende, M, Malvy, D, Pistone, T, Méchain, M, Duffau, P, Faure, I, Caldato, S, Bellecave, P, Pellegrin, J.L, Bioulac‐Sage, P, Reigadas, S, Majerholc, C, Polo Devoto, J, Kansau, I, Pignon, C, Dominguez, S, Lelièvre, J.D, Lascaux, A.S, Boutoille, D, Rodallec, A, Le Guen, L, Peyramond, D, Chidiac, C, Ferry, T, Zoulim, F, Lack, P, Maynard, M, Radenne, S, Amiri, M, Koffi, J, Zoulim, F, Bailly, F, Maynard, M, Scholtes, C, Chavanet, P, Duong Van Huyen, M, Galim, S, Batard, M.L, Bernard‐Henry, C, de Mautort, E

Get full text

Factors associated with deaths from suicide in a French nationwide HIV‐infected cohort by Hentzien, M, Cabie, A, Pugliese, P, Poizot‐Martin, I, Duvivier, C, Valantin, M‐A, Kaladjian, A, Dramé, M, Dellamonica, P, Cuzin, L, Cabié, A, Delpierre, C, Allavena, C, Katlama, C, Peytavin, G, Cheret, A, Chidiac, C, Isnard‐Bagnis, C, Cotte, L, Peyramond, D, Joly, V, Jovelin, T, Saune, K, Roger, P. M., May, T, Brégigeon, S, Soavi, M. J., Ressiot, E, Carta‐Padovani, M, Ducassou, M. J., Jaquet, I, Galie, S, Galinier, A, Landon, M, Ivanova, A, Debreux, C, Lions, C, Biezunski, N, Fourcade, C, Marchou, B, Martin‐Blondel, G, Porte, L, Mularczyk, M, Garipuy, D, Lepain, I, Marcel, M, Puntis, E, Bentz, L, Cua, E, Cottalorda, J, Fuzibet, J. G., Mondain, V, Naqvi, A, Prouvost‐Keller, B, Pradier, C, Wehrlen‐Pugliese, S, Bonnet, B, Bouchez, S, Brunet, C, Hall, N, Morineau, P, Reliquet, V, Aubry, O, Point, P, Besnier, M, Hüe, H, Cavellec, M, Soria, A, Sécher, S, André‐Garnier, E, Rodallec, A, Ferré, V, Lefebvre, M, Grossi, O, Choisy, P, Agher, R, Pierre‐François, S, Liautaud, B, Fischer, P, Partisani, M, Cheneau, C, Priester, M, Bernard‐Henry, C, Batard, M. L., Mautort, E, Gardiennet, Q, Berger, J. L., N'Guyen, Y, Lebrun, D, Migault, C, Kmiec, I, Ferry, T, Boibieux, A, Perpoint, T, Schlienger, I, Lippmann, J, Braun, E, Koffi, J, Guéripel, V, Degroodt, S

“…Objectives People living with HIV (PLHIV) are at a higher risk of dying by suicide than the general population. Epidemiological data regarding determinants of…”
Get full text

Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – “En route for eradication”? by Pradat, Pierre, Pugliese, Pascal, Poizot-Martin, Isabelle, Valantin, Marc-Antoine, Cuzin, Lise, Reynes, Jacques, Billaud, Eric, Huleux, Thomas, Bani-Sadr, Firouze, Rey, David, Frésard, Anne, Jacomet, Christine, Duvivier, Claudine, Cheret, Antoine, Hustache-Mathieu, Laurent, Hoen, Bruno, Cabié, André, Cotte, Laurent

“…Summary Objectives Direct-Acting Antivirals (DAAs) opened a new era in HCV treatment. We report the impact of HCV treatment in French HIV-HCV coinfected…”
Get full text

No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France by Cuzin, L, Yazdanpanah, Y, Huleux, T, Cotte, L, Pugliese, P, Allavena, C, Reynes, J, Poizot‐Martin, I, Zaegel‐Faucher, O, Obry‐Roguet, V, Soavi, MJ, Luquet‐Besson, I, Carta‐Padovani, M, Bertone, H, Galie, S, Galinier, A, Martinet, P, Ritleng, AS, Ivanova, A, Alvarez, M, Debard, A, Delobel, P, Martin‐Blondel, G, Porte, L, Mularczyk, M, Garipuy, D, Marcel, M, Puntis, E, Ceppi, C, Cua, E, Dellamonica, P, Dunais, B, Durant, J, Etienne, C, Ferrando, S, Risso, K, Mondain, V, Perbost, I, Wehrlen‐Pugliese, S, Rosenthal, E, Roger, PM, Billaud, E, Bonnet, B, Bouchez, S, Boutoille, D, Brunet‐Cartier, C, Jovelin, T, Hue, H, Rodallec, A, Vivrel, F, Biron, C, Cheret, A, Choisy, P, Landman, R, Duvivier, C, Agher, R, Lortholary, Rouzioux, C, Cessot, G, Touam, F, Usubillaga, R, Cabié, A, Abel, S, Pierre‐François, S, Ouka, M, Martial, J, Fischer, P, Partisani, M, Cheneau, C, Batard, ML, Bernard‐Henry, C, e Mautort, E, Drobacheff‐Thiébaut, C, Faucher, JF, Hustache‐Mathieu, L, Hoen, B, Jacomet, C, Lesens, O, Mrozek, N, Aumeran, C, Baud, O, Beytout, J, Coban, D, Casanova, S, Rouger, C, Berger, JL, N'Guyen, Y, Kmiec, I, Hentzien, M, Peyramond, D, Ader, F, Biron, F, Boibieux, A, Perpoint, T, Degroodt, S, Atoui, N, Casanova, ML, Le Moing, V, Meftah, N, Psomas, C

“…Objectives The aim of the study was to determine whether there is a relationship between social deprivation and time of HIV diagnosis in France. Methods…”
Get full text

Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load by Flandre, P, Pugliese, P, Allavena, C, Katlama, C, Cotte, L, Cheret, A, Cabié, A, Rey, D, Chirouze, C, Cuzin, L, Obry‐Roguet, V., Bregigeon, S., Poizot‐Martin, I., Marchou, B., Massip, P., Bonnet, E., Obadia, M., Alvarez, M., Porte, L., Delobel, P., Chauveau, M., Garipuy, D., Bernard, J., Lepain, I., Marcel, M., Puntis, E., Sauné, K., Ceppi, C., Cua, E., Cottalorda, J., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Sausse, S., Roger, P.M., Bernaud, C., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Hall, N., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, So, Ferré, V., André‐Garnier, E., Rodallec, A., Choisy, P., Yazdanpanah, Y., Landman, R., Duvivier, C., Agher, R., Consigny, P.H., Cessot, G., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Pierre‐François, S., Ouka, M., Martial, J., Ebel, E., Cheneau, C, Priester, M, Batard, ML, Bernard‐Henry, C, Mautort, E, Drobacheff‐Thiébaut, C., Faller, J.P., Faucher, J.F., Foltzer, A., Jacomet, C., Laurichesse, H., Lesens, O., Aumeran, C., Baud, O., Beytout, J., Coban, D., Casanova, S., Rouger, C., Peyramond, D., Chidiac, C., Ader, F., Boibieux, A., Miailhes, P, Perpoint, T.

“…Objectives To compare the efficacy, in current clinical practice, of first regimens containing abacavir with lamivudine (ABC/3TC) or tenofovir with…”
Get full text

Virologic Response of Zidovudine, Lamivudine, and Tenofovir Disoproxil Fumarate Combination in Antiretroviral-Naive HIV-1-Infected Patients by Rey, David, Krebs, Magali, Partisani, Marialuisa, Hess, Georgette, Cheneau, Christine, Priester, Michèle, Bernard-Henry, Claudine, de Mautort, Erik, Lang, Jean-Marie

“…BACKGROUND:High rates of virologic failure have been reported in antiretroviral-naive patients receiving triple-nucleoside reverse transcriptase inhibitor…”
Get full text

Tolerance of a Short Course of Nevirapine, Associated With 2 Nucleoside Analogues, in Postexposure Prophylaxis of HIV by Rey, David, Partisani, Marialuisa, Hess-Kempf, Georgette, Krantz, Véronique, Priester, Michèle, Cheneau, Christine, Bernard-Henry, Claudine, de Mautort, Erik, Decroix, Laetitia, Lang, Jean-Marie

“…A combination of 2 nucleoside analogues and 1 protease inhibitor is usually recommended in postexposure prophylaxis. Because of the complex treatment schedule…”
Get full text

Efavirenz as a Substitute for Protease Inhibitors in HIV-1-Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks by Rey, David, Schmitt, Marie-Paule, Partisani, Marialuisa, Hess-Kempf, Georgette, Krantz, Véronique, de Mautort, Erik, Bernard-Henry, Claudine, Priester, Michèle, Cheneau, Christine, Lang, Jean-Marie

“…We investigated, in a prospective cohort follow-up study, whether substituting efavirenz (EFV) for protease inhibitors (PIs) could be safe in HIV-infected…”
Get full text

Séroprévalence de l'hépatite A chez des patients infectés par le VIH by Rey, D., Frick-Michot, E., Partisani, M., Hess-Kempf, G., Cheneau, C., Priester, M., Bernard-Henry, C., de Mautort, E., Wendling, M.J., Meyer, P., Lang, J.M.

“…Objectifs. – Évaluer de manière prospective la séroprévalence du virus de l'hépatite A dans la population de patients infectés par le VIH suivis en hôpital de…”
Get full text

Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results by Rey, D, Schmitt, M P, Hess-Kempf, G, Krantz, V, Partisani, M, Bernard-Henry, C, Lang, J M

“…Structured therapeutic interruption (STI) has been offered to HIV-1 infected patients with virological failure (viral load > 1500 copies/mL) of potent…”
Get full text

Hepatitis A seroprevalence in HIV-infected patients by Rey, D, Frick-Michot, E, Partisani, M, Hess-Kempf, G, Cheneau, C, Priester, M, Bernard-Henry, C, de Mautort, E, Wendling, M J, Meyer, P, Lang, J M

“…The authors had for aim to prospectively study the hepatitis A seroprevalence of an HIV-infected population, followed-up in an outpatient clinic (CISIH…”
Get full text

D-06 Efficacite du tenofovir associé à la zidovudine et la lamivudine, chez des patients infectés par le VIH naifs d'antirétroviraux by Rey, D., Krebs, M., Partisani, M., Hess-Kempf, G., Cheneau, C., Priester, M., Bernard-Henry, C., de Mautort, E., Lang, J.-M.

Get full text

D-13 Séroprevalence de l'hépatite a chez des patients infectés par le VIH by Rey, D., Frick-Michot, E., Partisani, M., Hess-Kempf, G., Cheneau, C., Priester, M., Bernard-Henry, C., de Mautort, E., Wendling, M.-J., Meyer, P., Lang, J.-M.

Get full text